Montalar J, Cajaraville G, Carreras MJ, Rubio MJ, García-San Andrés B, Oyagüez I, Casado MA
Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD monotherapy in relapsed platinum-sensitive ovarian cancer patients: a cost-effectiveness analyses in Spain
Eur J Hosp Pharmacy. 2012;19:364-69
García Vargas M, Casado MA, Nir M, Barrueta JM
Análisis de costes de tres candinas en el tratamiento de la candidiasis invasora en pacientes adultos no neutropénicos en España
Farm Hosp. 2012;36:207-15
Roman A, Barberà JA, Escribano P, Sala ML, Febrer L, Oyagüez I, Sabater E, Casado MA
Cost effectiveness of prostacyclins in pulmonary arterial hypertension
Appl Health Econ Health Policy. 2012;10(3):175-88
García-Ruiz A, Perez-Costillas L, Montesinos AC, Alcalde J, Oyagüez I, Casado MA
Efficiency of antipsychotics in reducing schizophrenia relapses
Health Econ Rev. 2012;2:8
Grau S, de la Camara R, Sabater FJ, Jarque I, Carreras E, Casado MA, Sanz MA
Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain
BMC Infect Dis. 2012;12:83 doi:10.1186/1471-2334-12-83
Martínez-Raga J, González-Saiz F, Oñate J, Oyagüez I, Sabater E, Casado MA